Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 22:12:2-5.
doi: 10.1016/j.reth.2019.03.001. eCollection 2019 Dec 15.

"Microgravity" as a unique and useful stem cell culture environment for cell-based therapy

Affiliations
Review

"Microgravity" as a unique and useful stem cell culture environment for cell-based therapy

Takeshi Imura et al. Regen Ther. .

Abstract

Cell-based therapy using mesenchymal stem cells or pluripotent stem cells such as induced pluripotent stem cells has seen dramatic progress in recent years. Part of cell-based therapy are already covered by public medical insurance. Recently, researchers have attempted to improve therapeutic effects toward various diseases by cell transplantation. Culture environment is considered to be one of the most important factors affecting therapeutic effects, in particular factors such as physical stimuli, because cells have the potential to adapt to their surrounding environment. In this review, we provide an overview of the research on the effects of gravity alteration on cell kinetics such as proliferation or differentiation and on potential therapeutic effects, and we also summarize the remarkable possibilities of the use of microgravity culture in cell-based therapy for various diseases.

Keywords: CNS, central nervous system; ISS, International Space Station; MSCs, mesenchymal stem cells; Microgravity; RCCS, rotary cell culture system; Regenerative therapy; Stem cells; cMSCs, cranial bone-derived MSCs.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Multidirectional gravity control device “Gravite®” by the controlled rotation of two axes, this device minimizes the cumulative gravity vector at the center of the device, generating an average of 10−3 ×g over time. It can also realize 2 g or 3 g environment by the controlled rotation of one axis.

References

    1. Muroi K., Miyamura K., Okada M., Yamashita T., Murata M., Ishikawa T. Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade Ⅲ or Ⅳ acute graft-versus-host disease: a phase Ⅱ/Ⅲ study. Int J Hematol. 2016;103:243–250. - PubMed
    1. Le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–1441. - PubMed
    1. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–1586. - PubMed
    1. Shichinohe H., Kawabori M., Iijima H., Teramoto T., Abumiya T., Nakayama N. Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke. BMC Neurol. 2017;17:179. - PMC - PubMed
    1. Honmou O., Houkin K., Matsunaga T., Niitsu Y., Ishiai S., Onodera R. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Stroke. 2011;134:1790–1807. - PMC - PubMed

LinkOut - more resources